International Vaccine Institute
Scope
Date
~
-
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
M&As
Mubadala joins GS-led group to buy Korean botox maker
Abu Dhabi’s sovereign investor Mubadala Investment Co. joined a consortium led by South Korean GS Group to acquire the country’s top bot...
Aug 11, 2021 (Gmt+09:00)
language -
Energy
POSCO International, Petronas to develop Malaysian offshore gas field
POSCO International Co., the trading unit of South Korean steelmaker POSCO Co., is set to develop an offshore gas field in Malaysia with the country...
Aug 10, 2021 (Gmt+09:00)
-
COVID-19
SK Bioscience to kick off phase 3 vaccine trials
SK Bioscience Co. has received approval from South Korea’s Ministry of Food and Drug Safety (MFDS) for phase 3 clinical trials of its COVID-19...
Aug 10, 2021 (Gmt+09:00)
language -
COVID-19
Korean govt to spend $1.9 billion to become world’s leading vaccine maker
The South Korean government will invest 2.2 trillion won ($1.9 billion) by 2025 to become a top five vaccine producer in the world. President Moon J...
Aug 05, 2021 (Gmt+09:00)
-
COVID-19
War for bio talent intensifies as S.Korea works on mRNA vaccines
As concerns rise over a resurgence of the COVID-19 pandemic, the war for talent in South Korea’s pharmaceutical industry is intensifying as th...
Aug 05, 2021 (Gmt+09:00)
-
IPOs
Krafton sets IPO price at top end despite soft institutional demand
South Korean game developer Krafton Inc. set the initial public offering (IPO) price at the top end of the proposed band even as the largest domesti...
Jul 29, 2021 (Gmt+09:00)
-
IPOs
Krafton IPO draws tepid demand from institutional investors
South Korean game developer Krafton Inc.’s initial public offering, the largest domestic IPO in the second half, drew weaker demand from insti...
Jul 28, 2021 (Gmt+09:00)
-
COVID-19
COVID treatment deals drive Samsung Bio’s record quarterly earnings
South Korea’s Samsung Biologics Co. posted its highest quarterly revenue and operating profit, thanks largely to a number of long-term manufac...
Jul 28, 2021 (Gmt+09:00)
-
NPS to raise exposure to Kosdaq-listed blue chips
The National Pension Service (NPS) will raise exposure to up-and-coming biopharmaceutical, electric vehicle parts, entertainment and gaming companie...
Jul 18, 2021 (Gmt+09:00)
-
Real estate
Korean funds weigh overseas real estate exits in H2
Domestic office buildings and logistics centers dominated South Korean institutions' property transactions in the first half of this year, with fier...
Jul 14, 2021 (Gmt+09:00)
-
Energy
POSCO International, Pertamina seek joint oil, gas development off Indonesia
POSCO International Co., the trading unit of South Korean steelmaker POSCO, has agreed with Indonesia’s PT Pertamina Hulu Energi (PHE) to look...
Jul 05, 2021 (Gmt+09:00)
language -
COVID-19
Korea’s pharma consortium to develop mRNA vaccines by 2022
South Korea will develop its own messenger ribonucleic acid (mRNA) vaccines by next year with plans to annually manufacture 100 million doses from 2...
Jun 30, 2021 (Gmt+09:00)
language -
Aerospace & Defense
Hanwha to make satellite thrusters with Korea's aerospace institute
Hanwha Corp. will develop the bipropellant thruster, a key component for adjusting the satellite’s position in orbit, together with Korea Aero...
Jun 28, 2021 (Gmt+09:00)
language -
Private debt
Korean institutions ranked top US liquidity provider under 2020 TALF
South Korean institutional investors, including the Public Officials Benefit Association (POBA) and Yellow Umbrella Mutual Aid Fund, emerged as the ...
Jun 17, 2021 (Gmt+09:00)
-
COVID-19
CureVac may pick Korea as Asian base for COVID vaccine production
German biopharmaceutical company CureVac N.V. may choose South Korea as one of its global production bases for the COVID-19 vaccine following Korean...
Jun 16, 2021 (Gmt+09:00)
language -
Central bank
Bank of Korea governor sends stronger signal to raise rates this year
South Korea’s central bank governor on Friday flagged a tighter monetary policy for the second time in less than a month, fueling expectations...
Jun 11, 2021 (Gmt+09:00)
-
Korean stock market
Samsung returns as foreigners’ top pick; Kospi just shy of record high
Samsung Electronics Co., the bellwether of South Korea’s main bourse, has returned as the market darling, with foreigners buying heavily on th...
Jun 03, 2021 (Gmt+09:00)
language -
Automobiles
Hyundai tops Korean institutions' May buying list
Hyundai Motor became the key beneficiary of South Korean institutional investors' heavy buying on the local bourse this month as the global chip sho...
May 31, 2021 (Gmt+09:00)
-
COVID-19
SK Bioscience secures up to $173.4 mn from CEPI for vaccine development
SK Bioscience Co. has secured additional funding for phase III clinical trial of GBP510, its COVID-19 vaccine candidate jointly developed with the I...
May 24, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics to make Moderna’s mRNA vaccine from Q3
Samsung Biologics Co. will be manufacturing the US company Moderna’s COVID-19 vaccine (mRNA-1273) from the second half of this year in Korea. ...
May 23, 2021 (Gmt+09:00)
language -
COVID vaccines
Samsung Biologics in talks to produce Pfizer’s COVID-19 vaccine
South Korea’s Samsung Biologics Co. is in talks with Pfizer Inc.to produce the US drugmaker’s COVID-19 vaccine under a contract manufact...
May 12, 2021 (Gmt+09:00)
language -
COVID-19
Korean pharmas may turn into global vaccine makers on Biden remarks
South Korea’s biosimilar and pharmaceutical companies are looking at a growing chance of emerging as a global hub for manufacturing vaccines f...
May 07, 2021 (Gmt+09:00)
language -
COVID-19
Genexine exports COVID vaccine candidate to Indonesia
Genexine Inc., one of the five South Korean pharmaceutical companies whose COVID-19 vaccine candidates have entered clinical trials, will export its...
Apr 28, 2021 (Gmt+09:00)
language -
COVID-19
SK Bioscience halts flu vaccine output to focus on COVID vaccines
South Korea’s SK Bioscience Co. is suspending production of SKYCellflu, an influenza vaccine, to focus on manufacturing COVID-19 vaccines inst...
Mar 30, 2021 (Gmt+09:00)
language -
ESG
BOK tells institutions to cut exposure in high carbon sectors
The Bank of Korea has asked the country’s financial institutions to reduce exposure in economic sectors that generate high levels of carbon em...
Mar 25, 2021 (Gmt+09:00)
language -
COVID-19
Green Cross in talks with Russia to produce COVID-19 vaccine
South Korea’s pharmaceutical company Green Cross Corporation (GC) is holding a series of close meetings on contract manufacturing of Russia&rs...
Mar 18, 2021 (Gmt+09:00)
language -
COVID-19
SK Bioscience eyes $900 mn annual sales from vaccine business
South Korea’s SK Bioscience Co. is looking to post 1 trillion won ($900 million) in annual revenue from its vaccine business as the biopharmac...
Feb 23, 2021 (Gmt+09:00)
language -
Celltrion eyes COVID-19 vaccine development
South Korea-based Celltrion Inc. has alluded to the possibility of developing a COVID-19 vaccine on the grounds that securing a vaccine is essential...
Feb 19, 2021 (Gmt+09:00)
language -
Economy
Korea’s treasury yields climb on hopes of vaccines, more bond issues
South Korea’s treasury yields are heading higher as advances in vaccine development and concerns over increased government bond sales prompt f...
Dec 20, 2020 (Gmt+09:00)